Ginkgo Bioworks Stock Prediction and Forecast [DNA]

AI-generated source summary

The analysis for Ginkgo Bioworks (DNA) stock shows a buy signal from June 9, 2025, score of 2.87. Past performance indicates a 71.68% gain over 42 days, with an average daily gain of 1.71%. Short-term trend bullish. 79% change over the next 3 months, potential returns of 50% to 113%. An average return of 12.85% expected over 12 months. range of $7.05 to $19.59. The last trading day reports a 3.58% decrease at $13.46, fluctuating 8.79% between $13.13 and $14.28. Volume rose. 52 week low to $5.00 and high of $16.85. The price is 20.12% the 52-week high. Analysts rate the stock strong sell. Last transactions of Coen Steven P. show a 57.53 insider power. Volume rose on falling prices. Support identified at $13.36 and $11.50, with resistance at $13.96. A suggested stop-loss at $12.84.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   07 Aug 2025, 23:40 UTC

   The analyst published the original source item.

2. First prediction resolved

   08 Aug 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   08 Aug 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:10 UTC

   Tahlil Plus began monitoring the extracted predictions.